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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S440markers, were able to differentiate in vitro and in vivo into all three
germ layers (ectoderm, endoderm, and mesoderm), displayed normal
karyotypes, and showed silenced expression of retroviral genes.
During early differentiation towards mesendoderm, CD long iPSCs
maintained an epithelial-like morphology and had reduced expres-
sion of mesendoderm and epithelial-to-mesechymal transition (EMT)
genes compared to CD short and WT iPSCs. Further differentiation of
iPSCs towards chondroprogenitors revealed that CD long iPSCs had
reduced levels of proteoglycans and reduced expression of cartilage
genes compared to CD short and WT iPSCs. All iPSC lines were able to
form cartilage tissue expressing type II collagen and proteoglycans in
vivo with no gross morphological differences between WT and CD
tissues.
Conclusions: iPSCs can be derived from patients with heterozygous
mutations in SOX9 as SOX9 is not known to play a key role in pluri-
potency or reprogramming. CD short iPSCs differentiated efﬁciently
towards mesendoderm and chondroprogenitors, similar to WT iPSCs.
However, CD long iPSCs exhibited delayed differentiation towards
mesendoderm, affecting their capacity to differentiate towards
chondroprogenitors. This suggests SOX9 may play a role in speciﬁ-
cation to mesendoderm, one of the embryonic origins of cartilage
tissue. We have shown that different mutations in SOX9 can lead to
different phenotypic outcomes whose mechanisms can be inves-
tigated using iPSCs as a human in vitro model. Since SOX9 controls
expression of key extracellular matrix genes found in embryonic and
adult cartilage tissue, CD iPSC-derived chondroprogenitors can be
used to elucidate pathways in which aberrant expression of SOX9
leads to improper expression of these genes. Further, we have
established a differentiation protocol and set of assays that can be
applied to disease modelling of iPSCs derived from patients with
osteoarthritis.
797
CHEMOTAXIS OF CULTURED HUMANMESENCHYMAL STEM CELLS TO
OSTEOARTHRITIC CARTILAGE AND SYNOVIUM
M.J. Leijs, P.K. Bos, J.A. Verhaar, M.J. Hoogduijn, G.J. van Osch. Erasmus
MC, Rotterdam, Netherlands
Purpose:Mesenchymal stem cells (MSCs) are promising candidates for
cell therapy in osteoarthritis (OA). MSCs can differentiate to generate
repair cartilage tissue and they have potential immunomodulatory and
anti-inﬂammatory effects on synovium and cartilage. To be therapeutic
in OA, MSCs need to survive after intra-articular injection, probably by
migration towards or into affected tissues. Chemotactic factors secreted
by OA tissues and expression of chemotactic factor receptors by MSCs
could be involved in this migration. We studied the effect of the OA
environment on the migration of MSCs in culture and we studied
whether we could prime MSCs with inﬂammatory factors to inﬂuence
the expression of chemotactic factor receptors and thereby improve the
migration capacity.
Methods: MSCs were cultured in monolayer in serum-free medium
with 1% ITS at 20% O2 with(out) 50ng/ml, 20ng/ml or 1 ng/ml IFNg and
TNFa for 24 hours or with(out) 50% synovial ﬂuid (SF) of OA patients or
healthy donors for 48 hours. The expression of chemotactic factor
receptors CXCR1, CXCR3, CXCR4, CCR1, CCR4, CCR5, PDGFRa, PDGFRb
and CX3CR1 by MSCs was analysed by RT-PCR (related to HPRT as
housekeeper) and FACS. Chemotactic factors fractalkine, MCP-3, PDGF-
BB, MIP-1a, MIP-1b, MDC, PDGF-AA, IP10, IL-8 and MCP-1 secreted in
themedium by OA cartilage and synovium of six donors weremeasured
with a 10-plex milliplex assay. For the chemotaxis assay 6,000 MSCs
were seeded in transwell inserts (8.0um pores) and placed in 24-well
plates with OA synovium or cartilage conditioned medium (CM) for 18
hours. Migrated MSCs on the outside of the transwell membrane were
stained and counted.
Results: All chemotactic factor receptor genes were expressed in cul-
tured MSCs except for CXCR1. MSCs exposed to OA SF lead to an
increased mRNA expression of CCR1 and PDGFRa and a decreased
expression of PDGFRb (ﬁgure 1).
The chemotactic factors that bind on these receptors were present in OA
synovium. They were secreted by both OA cartilage and synovium; in
particular high amounts of MDC, IL-8 and MCP-1 were detected in the
CM. Additionally, differences in the composition of the chemokines
secreted by synovium and cartilage were obvious: synovium CM con-
tained higher amounts of MIP-1a and MIP-1b and cartilage CM con-
tained higher amounts of PDGF-AA and IP10.The chemotaxis assay then demonstrated that signiﬁcantly more MSCs
migrated towards OA synovium and cartilage CM compared to control
medium (ﬁgure 2).
Priming the MSCs with inﬂammatory factors IFNg and TNFa increased
the mRNA expression of CCR1 and CCR4 and decreased PDGFRa and
PDGFRbwith a clear dose response effect on the expression of CCR1 and
PDGFRa. The decreased expression of PDGFRa could be conﬁrmed with
FACS analyses. OA CM still had an chemotactic effect on primed MSCs,
however the chemotactic effect of OA CM was stronger on non-primed
MSCs compared to primed MSCs. http://ﬁles.abstractsonline.com/CTRL/
51/E/C61/29B/95C/475/69C/E31/591/FAC/899/02/g833_1.jpg
Fig. 1. MSCs exposed to OA SF; OA SF increased gene expression of CCR1
and PDGFRa (A-B) and decreased gene expression of PDGFRb (C). *p <
0.05; mean  SD; (OA) osteoarthritis, (SF) synovial ﬂuid.
Fig. 2. MSCs migrate to OA synovium and cartilage CM. *** p < 0.001;
mean  SD; (syn CM) synovium conditioned medium, (cart CM) cartilage
conditioned medium.Conclusion: MSCs expressed mRNA for chemo-
tactic factor receptors and migrated towards chemotactic factors
secreted by OA synovium and cartilage. Based on our in-vitro data, OA
SF will probably not have a negative effect on the expression of the
chemotactic factor receptors of intra-articularly injected MSCs. Priming
MSCs in culture with inﬂammatory factors before intra-articular
injection with the goal to improve the migration potential, inﬂuenced
the expression of different chemotactic factor receptor in MSCs, how-
ever did not improve chemotaxis. These data suggest that we should be
careful with priming MSCs (with inﬂammatory factors) to activate their
capacities or with injecting them into an inﬂammatory environment
and encourage further research to improve and optimize the ther-
apeutic capacities of MSCs for OA.
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TGFbMODULATES ITS OWN SIGNALING IN CHONDROGENIC CELLS BY
INDUCING ALK5 AND DAMPENING ALK1
L.M. de Kroon y,z, E.N. Blaney Davidson y, R. Narcisi z, M. Cleary z,
P.M. van der Kraan y, G.J. van Osch z. yRadboud Univ. Med. Ctr., Nijmegen,
Netherlands; z Erasmus Univ. Med. Ctr., Rotterdam, Netherlands
Purpose:Osteoarthritis and trauma lead to cartilage lesions that remain
unrepaired because cartilage is a tissue with poor regenerative capacity.
Bone marrow-derived mesenchymal stem cells (BMSCs) are a promis-
ing cell source to treat cartilage defects due to their capacity to
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S441differentiate into a chondrogenic lineage. Transforming Growth Factor-
b (TGFb) has a crucial role in chondrogenesis and can either signal via
type I receptor ALK5 or ALK1 in chondrogenic cells. Downstream ALK5
and ALK1 lead to different intracellular signaling routes; Smad2/3 and
Smad1/5/8 respectively. As TGFb is required for induction of chondro-
genic differentiation, we wondered whether TGFb could by itself alter
the receptor expression of ALK1 and ALK5, thereby modulating its own
signaling pathway.
Methods: Human BMSCs and dedifferentiated ACs were chondrogeni-
cally (re)differentiated in pellet culture in serum-free chondrogenic
medium containing 10nM dexamethasone and 25 mg/mL ascorbic acid,
with or without 10 ng/mL TGFb1. Pellets were harvested after 1, 4, 7, 14,
21, 28 and 35 days of chondrogenic induction for transcript analysis.
Relative mRNA levels of ALK1, ALK5, collagen type II and aggrecan were
measured using Q-RT-PCR. Values were corrected for ribosomal protein
S27a. To further evaluate the quality of the extracellular matrix
deposited by the cells, pellets were harvested after 21 and 35 days and
stained with Safranin O/Fast Green (proteoglycans) or immunostained
for collagen type II. An unpaired sample T-test was performed between
TGFb-stimulated and unstimulated pellets (n ¼ 3 pellets per time
point).
Results:Only pellets stimulatedwith TGFb displayed chondrogenesis as
measured by gene expression of collagen type II and aggrecan, and
immunohistochemical staining for proteoglycans and collagen type II.
Contrary to unstimulated pellets that were devoid of cartilage-like tis-
sue. In unstimulated BMSCs, ALK1 expression was upregulated during
the ﬁrst 4 days of culturing, while this upregulationwas absent in TGFb-
stimulated pellets. As a result, ALK1 expression remained stably lower
(w4-fold; p < 0.01) in the TGFb-stimulated compared to the unstimu-
lated condition from day 4 until the end of the culture period. In con-
trast, ALK5 expression was continuously increased by TGFb within the
ﬁrst 14 days of induction, remaining constantly higher (w10-fold; p <
0.001) than in unstimulated pellets during the remainder of the culture.
In pellets formed with dedifferentiated ACs, ALK1 expression rapidly
decreased in TGFb-stimulated pellets and stayed at a lower (w3-fold; p
< 0.01) level than in the unstimulated pellets until day 35. Expression of
ALK5 was higher (w10-fold; p < 0.0001) in ACs stimulated with TGFb
than in the control condition on day 1. After day 1, ALK5 expression
remained higher (w2-fold; p < 0.05) in TGFb-stimulated pellets com-
pared to unstimulated pellets, although the difference became smaller
with time during AC redifferentiation.
Conclusions: Our data show that TGFb modulates ALK1 and ALK5
expression in chondrogenic cells by stimulating ALK5 expressionwhilst
dampening ALK1 expression. This shows that TGFb not only directly
induces chondrogenic differentiation, but that it also modulates the
signaling pathways itself by altering the expression of the TGFb type I
receptors, ALK5 and ALK1 favoring ALK5. Unraveling the role and reg-
ulation of these receptors will help us to further improve the formation
of stable cartilage by BMSCs.
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EARLY INTRA-ARTICULAR INJECTION OF MESENCHYMAL STEM CELLS
PREVENTS SYNOVIAL INFLAMMATION AFTER MEDIAL MENISCAL
RELEASE IN A RABBIT MODEL OF OSTEOARTHRITIS
C. Boulocher y, N. Saulnier z, S. Maddens z, E. Pillet y, T. Roger y,
E. Viguier y. yVetAgro Sup, Veterinary Campus of Lyon, Marcy l’Etoile,
France; zVetbiobank, Marcy l’Etoile, France
Purpose: Osteoarthritis (OA) is characterized by a catabolic and
inﬂammatory joint environment. One of the main objective in the
management of OA is to dampen local inﬂammation in an attempt to
slow down cartilage degradation process and to relieve pain. Until
recently, Mesenchymal Stromal Cell (MSC) therapies for OA treatment
have mainly relied on their chondrogenic properties for cartilage repair.
The anti-inﬂammatory and immunomodulatory properties of Umbilical
Cord-Derived MSC (UC-MSC) has been rarely studied in the context of
the onset of the disease.
In the present study, we investigated the anti-inﬂammatory and anti-
catabolic effects of UC-MSC in a rabbit model of ﬁrst stage mild OA. We
examined the differential ability of an early or delayed intra-articular
(IA) injection of UC-MSC in preventing synovial inﬂammation, one of
the ﬁrst events leading ultimately to cartilage damage. The interactions
between MSC and the synovial membrane with regards to MSC anti-
inﬂammatory potentials were evaluated especially by analyses of the
expression of genes related to inﬂammation and matrix turnover. Thenature of the effects of UC-MSC on stimulated synoviocytes were fur-
ther investigated in vitro.
Methods: Medial meniscal release (MMR) was performed in rabbit
knee joints (day 0). A single early or delayed intra-articular (IA)
injection of UC-MSC was realized (day 3 or 15). At day 56, gross
morphology, Equilibrium Partitioning of an Ionic Contrast agent via
micro-CT (EPIC-mCT) and histology were performed to grade OA
lesions. Gene expression of inﬂammatory cytokines and metal-
loproteases was measured, in synovial tissue harvested from the OA
knees. In order to study the paracrine effects of UC-MSC, control rabbit
primary synoviocytes were incubated with UC-MSC-conditioned
medium or control medium under pro-inﬂammatory stimulus for 48 h
(Il-1b (10ng/ml)).
Results: As expected, at day 56, MMR procedure leads to changes con-
sistentwith earlyOA in themedial compartmentof the rabbit knee joints.
Cartilage ﬁbrillation, inﬂammatory cytokines and metalloproteases
gene expressions were lower in the early IA group than in the delayed
group. OA synovium gene expression analysis showed a reduction in the
expression of both the inﬂammatory cytokines (IL1b, TNFa) and the
metalloproteases (MMP-1, -3, -13) in the early-injected group com-
pared to the MMR group. UC-conditioned medium exerted anti-
inﬂammatory and anti-catabolic effects synoviocytes stimulated with
Il-1b. These results conﬁrmed UC-MSC possess paracrine activity that
target stimulated synoviocytes.
Conclusions: This study shows the efﬁciency of a single early IA
injection in preventing OA signs in rabbit knee following MMR. Early
UC-MSC IA injection might be more efﬁcient to reduce inﬂammation
and prevents OA progression than delayed UC-MSC IA injection.
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MAPPING OF THE WNT PATHWAY IN OSTEOARTHRITIC AND
HEALTHY SUBJECTS REVEALS AN INHERENTLY ALTERED PATTERN
IN OSTEOARTHRITIS MESENCHYMAL STEM CELLS
J.R. Lamas, A. Peralta-Sastre, P. Tornero-Esteban,
L. Rodríguez-Rodríguez, E. Herranz, B. Fernandez-Gutierrez. Hosp.
Clínico San Carlos (IdISSC), Madrid, Spain
Purpose: Osteoarthritis (OA) is characterized by homeostatic alter-
ations, resulting in abnormal restoration of damaged joint tissues by
progenitor mesenchymal stem cells (MSCs). Role of WNT signaling is
crucial in this process regulating MSCs proliferation and differ-
entiation to the osteogenic and chondrogenic lineages, the main
structural cell types of the joint. Using a targeted gene array, we aimed
to describe the expression ﬁngerprint of this pathway in OA patho-
genesis mapping the Wnt pathway integrity in MSCs and mature
chondrocytes.
Methods: Total RNA from MSCs and mature chondrocytes (C) cell cul-
tures was isolated from 10 OA patients (OA-MSCs ¼3 and OA-C ¼ 7) and
11 healty controls (MSCs ¼ 8 and C ¼ 3). Analysis of differential tran-
script expression of two metalloproteases, two collagen genes and 20
genes mapping the WNT signal transduction pathway were evaluated
using real-time quantitative PCR.
Results: Compared with healthy MSCs, expression of the transcription
factor gene LEF1 and the WNT5A ligand were signiﬁcantly down-
regulated and ADAMTS4 and BMP2 were upregulated in OA-MSCs.
Healthy mature chondrocytes showed an upregulation of BMP2, SOX9
and JUN. Downregulation of the JUN transcription factor concomitant
with an upregulation of kinases CSNK1A1 and GSK3Bwas present in OA-
Chondrocytes compared with healthy chondrocytes that also showed
an upregulation of LRP5 correceptor compared with OA-MSCs.
Conclusions: Expression of WNT related genes show a pattern of var-
iation in expression among MSCs and chondrocytes from OA and
healthy samples that point to inherent alterations in OA-MSCs that
determine their future chondrogenic phenotype in terms of a more
reduced chondogenic potential and an increased catabolic environ-
ment.
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SYNOVIAL ACTIVATION DRIVES ANIT-INFLAMMATORY EFFECTS OF
ADIPOSE-DERIVED STEM CELLS AFTER LOCAL ADMINISTRATION IN
EXPERIMENTAL OA WHICH IS REFLECTED BY S100A8/A9 LEVELS IN
THE SERUM
P. van Lent y, R. Schelbergen y, S. van Daalen y, A. Blom y, J. Roth z,
T. Vogl z, C. Jorgensen x, W. van den Berg y. yRadboud Univ. Med. Ctr.,
